文献速递眼底病与葡萄膜炎眼整形与眼眶小儿眼科与斜弱视

基于初诊表现的高危病理特征预测晚期眼内视网膜母细胞瘤:一项多中心、国际数据共享的美国癌症联合委员会研究

High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study.
PubMed 文献 · Ophthalmology · 2022-04-15

研究基于13国18个眼科肿瘤中心2001至2013年登记的942只初治眼球摘除的视网膜母细胞瘤眼,评估AJCC cT3亚类及AJCC OOTF大小分组对高危病理特征(pT3/pT4)的预测价值;282只(30%)眼存在高危病理特征,cT3c、cT3d、cT3e及大小分组3和4均为预测因素。

要点

  • 942只初治眼球摘除眼中282只(30%)存在高危病理特征。
  • cT3c、cT3d、cT3e较cT2a的OR分别为2.3、2.5和3.3(P值分别为0.002、0.002、0.019)。
  • 大小分组3和4较分组1的OR分别为3.3和4.1(P均<0.001)。

核心结论

  • AJCC cT3c至cT3e亚类及AJCC OOTF大小分组3和4均能对临床危险因素进行分层,可用于预测高危病理特征的存在,从而辅助治疗决策。

研究设计与样本

  • 国际、多中心、基于登记数据的回顾性病例系列,纳入13个国家18个眼科肿瘤中心2001至2013年间登记的942只以初治眼球摘除治疗的视网膜母细胞瘤眼。

主要发现

  • 942只初治眼球摘除眼中282只(30%)显示高危病理特征。
  • cT亚类与AJCC OOTF大小分组均与高危病理特征相关(两者P均<0.001)。
  • logistic回归中,与cT2a相比,cT3c(虹膜新生血管伴青光眼)、cT3d(眼内出血)、cT3e(无菌性眶蜂窝织炎)预测高危病理特征的OR分别为2.3(P=0.002)、2.5(P=0.002)、3.3(P=0.019)。
  • 与大小分组1(眼球体积<50%)相比,大小分组3(眼球体积超过三分之二)和分组4(弥漫浸润型视网膜母细胞瘤)的OR分别为3.3和4.1(两者P均<0.001)。

关键数值与推荐

  • 高危病理特征定义为AJCC pT3和pT4。
  • AJCC OOTF大小分组定义为:分组1为眼球体积受累不足一半,分组2为超过一半但不足三分之二,分组3为超过三分之二,分组4为弥漫浸润型视网膜母细胞瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the value of clinical features for advanced intraocular retinoblastoma as defined by the eighth edition of the American Joint Committee on Cancer (AJCC) cT3 category and AJCC Ophthalmic Oncology Task Force (OOTF) Size Groups to predict the high-risk pathologic features. DESIGN: International, multicenter, registry-based retrospective case series. PARTICIPANTS: Eighteen ophthalmic oncology centers from 13 countries over 6 continents shared evaluations of 942 eyes enucleated as primary treatment for AJCC cT3 and, for comparison, cT2 retinoblastoma. METHODS: International, multicenter, registry-based data were pooled from patients enrolled between 2001 and 2013. High-risk pathologic features were defined as AJCC categories pT3 and pT4. In addition, AJCC OOTF Size Groups were defined as follows: (1) less than half, (2) more than half but less than two thirds, (3) more than two thirds of globe volume involved, and (4) diffuse infiltrating retinoblastoma. MAIN OUTCOME MEASURES: Statistical risk of high-risk pathologic features corresponding to AJCC cT3 subcategories and AJCC OOTF Size Groups. RESULTS: Of 942 retinoblastoma eyes treated by primary enucleation, 282 (30%) showed high-risk pathologic features. Both cT subcategories and AJCC OOTF Size Groups (P < 0.001 for both) were associated with high-risk pathologic features. On logistic regression analysis, cT3c (iris neovascularization with glaucoma), cT3d (intraocular hemorrhage), and cT3e (aseptic orbital cellulitis) were predictive factors for high-risk pathologic features when compared with cT2a with an odds ratio of 2.3 (P = 0.002), 2.5 (P = 0.002), and 3.3 (P = 0.019), respectively. Size Group 3 (more than two-thirds globe volume) and 4 (diffuse infiltrative retinoblastoma) were the best predictive factors with an odds ratio of 3.3 and 4.1 (P < 0.001 for both), respectively, for high-risk pathologic features when compared with Size Groups 1 (i.e., < 50% of globe volume). CONCLUSIONS: The AJCC retinoblastoma staging clinical cT3c-e subcategories (glaucoma, intraocular hemorrhage, and aseptic orbital cellulitis, respectively) as well as the AJCC OOTF Size Groups 3 (tumor more than two thirds of globe volume) and 4 (diffuse infiltrative retinoblastoma) both allowed stratification of clinical risk factors that can be used to predict the presence of high-risk pathologic features and thus facilitate treatment decisions.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Tomar AS, Finger PT, Gallie B, et al. High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study. Ophthalmology. 2022. PMID: 35436535. doi:10.1016/j.ophtha.2022.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。